There is need for anti-malarial combination therapy (ACT) comprising of at least one partner drug with a new mechanism of action to reduce developing resistance.
The purpose of this study is to evaluate the parasiticidal effects and potential for cure with different anti-malarial agents administered as monotherapy and/or in combination with other anti-malarial agents in adults, children, adolescents, with uncomplicated P. falciparum malaria
Expected impact: Offer an option of anti-malarial treatment with a new mechanism of action, and an alternative drug for patients infected with resistant parasites.
